首页 正文

Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective Study

{{output}}
Background: Real-world data on low-dose emicizumab in young children with hemophilia A are limited. Methods: This multicenter retrospective stu... ...